SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a)
of the Securities Exchange Act of 1934
Filed by the registrant / /
Filed by a party other than the registrant /X/
Check the appropriate box:
/ / Preliminary proxy statement
/ / Definitive proxy statement
/X/ Definitive additional materials
/ / Soliciting material pursuant to Rule 14a-11(c) or Rule 14(a)-12
MEDICAL IMAGING CENTERS OF AMERICA, INC.
- --------------------------------------------------------------------------------
(Name of Registrant as Specified in Charter)
STEEL PARTNERS COMMITTEE
- --------------------------------------------------------------------------------
(Name of Person(s) filing Proxy Statement)
Payment of filing fee (check the appropriate box):
/ / $125 per Exchange Act Rule 0-11(c)(1)(ii), 14a-6(i)(1), or
14a-6(j)(2).
/X/ $500 per each party to the controversy pursuant to Exchange
Act Rule 14a-6(i)(3).
/ / Fee computed on table below per Exchange Act Rules 14a-6(i)(4)
and 0-11.
(1) Title of each class of securities to which transaction applies:
- --------------------------------------------------------------------------------
(2) Aggregate number of securities to which transaction applies:
- --------------------------------------------------------------------------------
(3) Per unit price or other underlying value of transaction
computed pursuant to Exchange Act Rule 0-11: (1)
- --------------------------------------------------------------------------------
(4) Proposed maximum aggregate value of transaction:
- --------------------------------------------------------------------------------
- --------
(1) Set forth the amount on which the filing fee is calculated
and state how it was determined.
<PAGE>
/X/ Check box if any part of the fee is offset as provided by
Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by registration statement
number, or the form or schedule and the date of its filing.
(1) Amount previously paid:
$500
- --------------------------------------------------------------------------------
(2) Form, schedule or registration statement no.:
- --------------------------------------------------------------------------------
(3) Filing party:
- --------------------------------------------------------------------------------
(4) Date filed:
- --------------------------------------------------------------------------------
-2-
<PAGE>
CONTACTS FOR STEEL PARTNERS:
Daniel Burch (212) 929-5748
Jeanne Carr (212) 929-5916
FOR IMMEDIATE RELEASE:
STEEL PARTNERS COMMENCES SUIT AGAINST MEDICAL IMAGING
SEEKS TO INVALIDATE THE POISON PILL
New York, New York -- February 16, 1996 -- STEEL PARTNERS II, L.P., a New York
based investment partnership, announced today that it has commenced a suit for
judgment declaring that the Shareholder Rights Plan of Medical Imaging Centers
of America, Inc. ("NASDAQ; MIGA") is invalid and illegal under the California
General Corporation Law. Steel Partners alleges in its Complaint that the Rights
Plan, commonly known as a "Poison Pill", unfairly discriminates among
shareholders. Steel Partners also alleges that, but for the "Poison Pill", it
would have purchased more shares of Medical Imaging in 1995 and/or early 1996.
Thomas Fleming of Olshan Grundman Frome & Rosenzweig LLP, attorneys for Steel
Partners stated, "We believe that the Medical Imaging poison pill violates the
fundamental rights of shareholders under California law."
Steel Partners is soliciting proxies from Medical Imaging's stockholders to
replace the present Board of Directors at a Special Meeting of Shareholders
scheduled for February 26, 1996.
The Steel Partners Committee is made up of Steel Partners and Steel Partners
Services, Ltd. The members of the Committee hold 527,682 shares, or 19.9%, of
Medical Imaging's common stock. The Committee's nominees for election to the
board of directors of Medical Imaging are Warren Lichtenstein, Lawrence Butler,
Jack L. Howard, David C. Flaugh and Steven Wolosky.
# # #
